Working… Menu

Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00030186
Recruitment Status : Completed
First Posted : February 8, 2002
Last Update Posted : August 23, 2012
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Cephalon )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 2003
Actual Study Completion Date : February 2003
Certification/Extension First Submitted : May 3, 2012